Pure Global AI
NCT06052605Not yet recruiting

Healthy Aging in People With Epilepsy Program

Healthy Aging in People With Epilepsy Program (HAP-E): Closing the Gap in Epilepsy Care
University of California, San DiegoClinicalTrials.govbehavioral
Study focus
Disease/Condition
Epilepsy
Drug/Device/Intervention
Healthy Aging in People with Epilepsy Program
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
University of California, San Diego
Location
San Diego, United States of America
Timeline & enrollment
Phase
N/A
Start date
Aug 01, 2024
End date
Jun 01, 2029
Enrollment
90 participants
Primary outcome

Dementia Knowledge,Health literacy,Health Related Quality of life

Summary

The goal of this clinical trial is to develop and test an educational program about dementia
 in older adults living with epilepsy. The main questions it aims to answer are:
 
 1. Can providing education on healthy aging, chronic disease management, dementia, and
 modifiable lifestyle dementia risk factors improve dementia knowledge and health
 literacy among older adults with epilepsy?
 
 2. Can aging related education and resources improve quality of life among older adults
 with epilepsy?
 
 Participants will:
 
 - Complete a 12-week group educational program.
 
 - Complete pre- and post-program evaluation.

ICD-10 classifications
EpilepsyEpilepsy, unspecifiedOther epilepsyStatus epilepticusOther status epilepticus
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06052605
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06052605 through Pure Global AI's free database. This phase not specified trial is sponsored by University of California, San Diego and is currently Not yet recruiting. The study focuses on Epilepsy. Target enrollment is 90 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.